Gamma Biotherapeutics, Inc.
Portland, OR Doing business as Straterx Inc.
- UEI
- FT1KYBH6T2F9
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 17624 NW Waltuck Ct, Portland, OR 97229, USA
- Website
- gammabiotherapeutics.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Clinical development of the anti-FAS ligand monoclonal antibody M3T01 for treatment of advanced cancers | National Cancer Institute (NIH) | $979,068 |
Quick answers
Is Gamma Biotherapeutics, Inc. registered in SAM.gov?
Yes. Gamma Biotherapeutics, Inc.'s SAM.gov registration is active through July 31, 2027.
What is Gamma Biotherapeutics, Inc.'s most recent federal award?
Gamma Biotherapeutics, Inc.'s most recent federal grant award is Clinical development of the anti-FAS ligand monoclonal antibody M3T01 for treatment of advanced cancers (R44CA310416), from National Cancer Institute (NIH), on August 11, 2026.
On GovTribe
See Gamma Biotherapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors